Evidence map›Paper›PMID 34559375›Full record

ArticleMetabolic brain disease2021

Stress load and neurodegeneration after gastrostomy tube placement in amyotrophic lateral sclerosis patients.

L Brylev, V Fominykh, V Chernenkaia, I Chernenkiy, K Gorbachev, A Ataulina, A Izvekov, M Monakhov, A Olenichev, S Orlov and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolic brain disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 1 country.

L BrylevBujanov Moscow City Clinical Hospital, Moscow, Russia.
V FominykhBujanov Moscow City Clinical Hospital, Moscow, Russia. hydrohinon@mail.ru.
V ChernenkaiaBujanov Moscow City Clinical Hospital, Moscow, Russia.
I ChernenkiyBauman Moscow State Technical University, Moscow, Russia.
K GorbachevBujanov Moscow City Clinical Hospital, Moscow, Russia.
A AtaulinaBujanov Moscow City Clinical Hospital, Moscow, Russia.
A IzvekovMukhin Moscow City Clinical Hospital, Moscow, Russia.
M MonakhovBujanov Moscow City Clinical Hospital, Moscow, Russia.
A OlenichevBujanov Moscow City Clinical Hospital, Moscow, Russia.
S OrlovBujanov Moscow City Clinical Hospital, Moscow, Russia.
I TurinMoscow City Clinical Hospital №40, Moscow, Russia.
M LoginovBujanov Moscow City Clinical Hospital, Moscow, Russia.
S RautbartBujanov Moscow City Clinical Hospital, Moscow, Russia.
A BaymukanovBujanov Moscow City Clinical Hospital, Moscow, Russia.
V Parshikov"Live Now" Charity Foundation for supporting people with ALS and other neuromuscular disorders, Moscow, Russia.
V Demeshonok"Live Now" Charity Foundation for supporting people with ALS and other neuromuscular disorders, Moscow, Russia.
A YakovlevInstitute of Higher Nervous Activity and Neurophysiology, Moscow, Russia.
T DruzhkovaMoscow Research and Clinical Center for Neuropsychiatry, Moscow, Russia.
A GuekhtMoscow Research and Clinical Center for Neuropsychiatry, Moscow, Russia.
N GulyaevaInstitute of Higher Nervous Activity and Neurophysiology, Moscow, Russia.
City Clinical Hospital · RUMoscow Research and Clinical Center for Neuropsychiatry · RUBauman Moscow State Technical University · RUInstitute of Higher Nervous Activity and Neurophysiology · RUPirogov Russian National Research Medical University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysphagia and progressive swallowing problems due to motoneuron death is one of amyotrophic lateral sclerosis (ALS) symptoms. Malnutrition and body weight loss result in immunological disturbances, fatigability and increase risk of secondary complications in ALS patients, percutaneous endoscopic gastrostomy tube (PEG) placement representing a well-recognized method for malnutrition correction and potentially increasing life expectancy. However, despite nutritional correction, occasional rapid neurological deterioration may develop after PEG placement. We have hypothesized that this decline can be a result of exteroceptive stress during PEG placement and promote neurodegeneration in ALS patients. Intravenous sedation may decrease stress during invasive procedures and it is safe during PEG placement in ALS patients. The aim of the study was comparing different PEG placement protocols of anesthesia (local anesthesia or local anesthesia plus intravenous sedation) in ALS from perspectives of stress load and neurological deterioration profile. During 1.5 years 94 ALS patients were admitted; gastrostomy was performed in 79 patients. After screening according to inclusion and exclusion criteria, 30 patients were included in the prospective consecutive study. All patients were divided in two groups, with local anesthesia and with combination of local anesthesia and intravenous sedation. Routine biochemical indices, neurodegeneration and stress markers were measured. The age of ALS patients was 61 ± 10 years; 20 patients were included at stage 4A and 10 at stage 4B (King's College staging). PEG was placed at average14 months after the diagnosis and 2.2 years after first symptoms. Mean ALS Functional Rating Scale-Revised was 27.8, mean forced vital capacity of lung 46.3% (19-91%). After one year of observation only 8 patients survived. Mean life duration after PEG was 5 months (5 days-20 months). Comparison of two PEG placement protocols did not reveal differences in survival time, stress load and inflammation level. Higher saliva cortisol levels, serum cortisol, glucose, C-reactive protein and interleukin-6 were detected after PEG placement, confirming considerable stress response. PEG is a stressful factor for ALS patients, PEG placement representing a natural model of exteroceptive stress. Stress response was detected as increased cortisol, C-reactive protein, interleukin-6, and glucose levels. Intravenous sedation did not increase the risk of PEG placement procedure, however, sedation protocol did not affect stress load.

Indexed as

Amyotrophic Lateral SclerosisDeglutition DisordersAgedGastrostomyHumansMiddle AgedProspective StudiesRetrospective StudiesVital CapacityALSGastrostomyNeurodegenerationNeuroinflammationSedationStress

Identifiers

PMID34559375
OpenAlexW3199529799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.